BridgeBio Oncology Therapeutics, Inc. Common Stock BBOT
$2.70
-3.57%
at last close
Dividend
BridgeBio Oncology Therapeutics, Inc. Common Stock (BBOT) does not currently pay a regular dividend, based on the most recent data available. Companies that retain earnings instead of paying dividends often reinvest in growth; check the financials page for how BridgeBio Oncology Therapeutics, Inc. Common Stock deploys its earnings.
Key Stats
- Last Close
- $2.70
- Market Cap
- $224.49 million
- 52-Week Range
- $2.51 – $14.87
- Average Volume
- 631K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.